Pulmonx Corp (LUNG) stock

LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/3040% below fair value

$2.86−0.14 (-4.67%)

Close on Nov 13, 2026Market cap $122.83MP/E –Yield –

Pulmonx total assets

Total assets on the balance sheet at the end of each period.

Pulmonx's total assets was $110.21M at Sep 30, 2026. For fiscal 2025 it was $129.29M, down 20.6% from the year before. The highest annual figure on record is $263.71M in fiscal 2020.

Annual total assets

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$129.29M	-20.6%
FY2024	Dec 31, 2024	$162.85M	-8.4%
FY2023	Dec 31, 2023	$177.78M	-8.2%
FY2022	Dec 31, 2022	$193.68M	-17.6%
FY2021	Dec 31, 2021	$235.17M	-10.8%
FY2020	Dec 31, 2020	$263.71M	+392.6%
FY2019	Dec 31, 2019	$53.53M	–

Quarterly total assets

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	$110.21M	-20.3%
Q2 FY2026	Jun 30, 2026	$114.73M	-22.1%
Q1 FY2026	Mar 31, 2026	$119.97M	-20.4%
Q4 FY2025	Dec 31, 2025	$129.29M	-20.6%
Q3 FY2025	Sep 30, 2025	$138.28M	-17.4%
Q2 FY2025	Jun 30, 2025	$147.19M	-14.7%
Q1 FY2025	Mar 31, 2025	$150.74M	-8.4%
Q4 FY2024	Dec 31, 2024	$162.85M	-8.4%
Q3 FY2024	Sep 30, 2024	$167.40M	-9.5%
Q2 FY2024	Jun 30, 2024	$172.63M	-10.6%
Q1 FY2024	Mar 31, 2024	$164.58M	-18.2%
Q4 FY2023	Dec 31, 2023	$177.78M	-8.2%
Q3 FY2023	Sep 30, 2023	$185.02M	-8.5%
Q2 FY2023	Jun 30, 2023	$193.11M	-9.2%
Q1 FY2023	Mar 31, 2023	$201.27M	-9.7%
Q4 FY2022	Dec 31, 2022	$193.68M	-17.6%
Q3 FY2022	Sep 30, 2022	$202.20M	-18.1%
Q2 FY2022	Jun 30, 2022	$212.73M	-14.5%
Q1 FY2022	Mar 31, 2022	$222.85M	-12.7%
Q4 FY2021	Dec 31, 2021	$235.17M	-10.8%
Q3 FY2021	Sep 30, 2021	$246.82M	+246.4%
Q2 FY2021	Jun 30, 2021	$248.94M	+365.0%
Q1 FY2021	Mar 31, 2021	$255.27M	–
Q4 FY2020	Dec 31, 2020	$263.71M	–
Q3 FY2020	Sep 30, 2020	$71.24M	–
Q4 FY2019	Dec 31, 2019	$53.53M	–